Success Metrics

Active Trials
1(20%)

Phase Distribution

Ph phase_2
5
100%

Phase Distribution

0

Early Stage

5

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
5(100.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Other(4)

Detailed Status

unknown4
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 25 (100.0%)

Trials by Status

recruiting120%
unknown480%

Recent Activity

1 active trials
Showing 5 of 5
recruitingphase_2

68Ga-NY104 PET/CT Guided Radiation Therapy in CcRCC.

NCT06613269
unknownphase_2

68Ga-NY104 PET/CT in Patients With Metastatic Clear Cell Renal Cell Carcinoma

NCT05879471
unknownphase_2

68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses

NCT05879510
unknownphase_2

68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion

NCT05879497
unknownphase_2

68Ga-NY104 PET/CT Imaging in Renal Cell Carcinoma

NCT05902377

Clinical Trials (5)

Showing 5 of 5 trials
NCT06613269Phase 2

68Ga-NY104 PET/CT Guided Radiation Therapy in CcRCC.

Recruiting
NCT05879471Phase 2

68Ga-NY104 PET/CT in Patients With Metastatic Clear Cell Renal Cell Carcinoma

Unknown
NCT05879510Phase 2

68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses

Unknown
NCT05879497Phase 2

68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion

Unknown
NCT05902377Phase 2

68Ga-NY104 PET/CT Imaging in Renal Cell Carcinoma

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
5